European Union Approves the Usage of COVID-19 Vaccine

Hours after the European Medicines Agency (EMA) made a positive scientific assessment, the European Union (EU) has approved the usage of the Pfizer/BioNTech vaccine against the novel coronavirus.

"We approved the first safe and effective vaccine against Covid-19. More vaccines will come soon. Doses of the vaccine approved today will be available for all EU countries, at the same time, on the same conditions," Xinhua news agency quoted European Commission President Ursula von der Leyen as saying on Monday night.

Effects of COVID-19 Vaccine and Male Fertility
New study sheds light on the impact of the COVID-19 vaccine on male fertility. Study has confirmed that the COVID-19 virus can affect sperm production inside the testes.

‘According to the World Health Organization, 222 Covid-19 candidate vaccines were being developed worldwide currently, with 56 of them under clinical trials.’

Efforts have been made to enable the delivery of the first doses on December 26 so that vaccination can start on December 27, said an EU statement.

A total of 200 million doses were expected to be distributed by September 2021, with 100 million more optional.

Earlier on Monday, EMA chief Emer Cooke confirmed that the positive assessment was backed by robust scientific data based on more than 40,000 clinical trials.

WHO Official Says COVID-19 Vaccines Not a Silver Bullet
Coronavirus vaccine is not a silver bullet that will end the nearly year-long pandemic which has infected over 74 million people across the globe, said a top WHO official.

The vaccine can be administered to people aged over 16.

The assessment and the following conditional marketing authorization came as news broke about that a new strain of the coronavirus, which was found mainly in Britain, prompted countries to impose restrictions on flights to and from the UK.

Five Strategies to Foster National COVID-19 Vaccine Program
Five new strategies and implementation considerations, informed by insights from behavioral science, could help effectively implement national COVID-19 vaccine promotion program.

Cooke said there was no evidence to suggest that the jab could not work against this new strain.

The Amsterdam-based agency had originally planned to meet on December 29 but brought the meeting forward as the need for a vaccine became more urgent because of a surge in the number of cases Europe-wide.

US States to Start Getting COVID-19 Vaccine from Monday, Say Sources
An official of President Donald Trump's administration said the first shipments of the Pfizer-BioNTech COVID-19 vaccine will begin arriving in US states from Monday.

The urgency also emerged after both the UK and the US gave their approval to the same jab weeks ago.

Source-IANS